Sun Pharma share price dropped after the company posted a mixed bag of results in the March quarter of financial year 2025 ...

Sun Pharma posted a 19% drop in Q4 profit to ₹2,153.9 crore, while revenue rose 8.5%. India formulation sales grew 13.6%, and ...

Merck & Co. is undervalued with strong oncology growth, key R&D investments, and shareholder returns. Click here to read an ...

Israel bought $91.5bn worth of goods from around the world in 2024. The biggest exporters to Israel were China with $19bn, ...

India’s largest drugmaker plans a $100 million push into US specialty drugs in FY26, even as it braces for regulatory ...

JSW Steel's consolidated revenue for the March quarter is expected to rise 10% on a sequential basis, while Aditya Birla ...

Shares of Chinese companies Jiangsu Hengrui Pharmaceuticals and Mirxes Holdings rose sharply on Friday in Hong Kong trading debuts after raising a combined $1.4 billion in separate listings.

Donald Trump explained during the unveiling of Robert F. Kennedy Jr.’s “Make America Healthy Again” report Thursday that his ...

Fintel reports that on May 22, 2025, HC Wainwright & Co. downgraded their outlook for UroGen Pharma (NasdaqGM:URGN) from Buy ...

Additionally, the Department of Health and Human Services unveiled the framework for the Most Favored Nation drug pricing ...

India's healthtech space is expected to witness disruption as weight loss drugs Ozempic and Mounjaro enter the market through ...

Kaddis said insurers are locked in a cat-and-mouse game with drugmakers as the insurance sector invests in biosimilars and ...